speb/financial-data huggingface dataset:
BABA balance_sheet (annual, 2026-03-31) — Capital Lease Obligations: 21726000000.00
BABA balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 21726000000.00
BABA balance_sheet (annual, 2026-03-31) — Capital Stock: 1000000.00
BABA balance_sheet (quarterly, 2026-03-31) — Capital Stock: 1000000.00
BABA balance_sheet (annual, 2026-03-31) — Cash And Cash Equivalents: 131530000000.00
BABA balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 131530000000.00
BABA balance_sheet (annual, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 316894000000.00
BABA balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 316894000000.00
BABA cash_flow (annual, 2026-03-31) — Cash Dividends Paid: -33732000000.00
BABA cash_flow (annual, 2026-03-31) — Cash Flow From Continuing Financing Activities: -20573000000.00
BABA cash_flow (annual, 2026-03-31) — Cash Flow From Continuing Investing Activities: -67336000000.00
BABA cash_flow (annual, 2026-03-31) — Cash Flow From Continuing Operating Activities: 76213000000.00
BABA cash_flow (annual, 2026-03-31) — Change In Accrued Expense: 37933000000.00
BABA cash_flow (annual, 2026-03-31) — Change In Income Tax Payable: -1973000000.00
BABA cash_flow (annual, 2026-03-31) — Change In Other Working Capital: 9424000000.00
BABA cash_flow (annual, 2026-03-31) — Change In Payable: -1973000000.00
BABA cash_flow (annual, 2026-03-31) — Change In Payables And Accrued Expense: 35960000000.00
BABA cash_flow (annual, 2026-03-31) — Change In Prepaid Assets: -67931000000.00
BABA cash_flow (annual, 2026-03-31) — Change In Tax Payable: -1973000000.00
BABA cash_flow (annual, 2026-03-31) — Change In Working Capital: -22547000000.00
BABA cash_flow (annual, 2026-03-31) — Changes In Cash: -11696000000.00
BABA cash_flow (quarterly, 2026-03-31) — Changes In Cash: 4112000000.00
BABA balance_sheet (annual, 2026-03-31) — Common Stock: 1000000.00
BABA balance_sheet (quarterly, 2026-03-31) — Common Stock: 1000000.00
BABA balance_sheet (annual, 2026-03-31) — Common Stock Equity: 1060886000000.00
BABA balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 1060886000000.00
BABA cash_flow (annual, 2026-03-31) — Common Stock Issuance: 1042000000.00
BABA cash_flow (annual, 2026-03-31) — Common Stock Payments: -7638000000.00
BABA balance_sheet (annual, 2026-03-31) — Construction In Progress: 59424000000.00
BABA balance_sheet (quarterly, 2026-03-31) — Construction In Progress: 59424000000.00
BABA income_statement (annual, 2026-03-31) — Cost Of Revenue: 616136000000.00
BABA income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 159392000000.00
BABA balance_sheet (annual, 2026-03-31) — Current Accrued Expenses: 32457000000.00
BABA balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 32457000000.00
BABA balance_sheet (annual, 2026-03-31) — Current Assets: 610769000000.00
BABA balance_sheet (quarterly, 2026-03-31) — Current Assets: 610769000000.00
BABA balance_sheet (annual, 2026-03-31) — Current Capital Lease Obligation: 4318000000.00
BABA balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 4318000000.00
BABA balance_sheet (annual, 2026-03-31) — Current Debt: 28224000000.00
BABA balance_sheet (quarterly, 2026-03-31) — Current Debt: 28224000000.00
BABA balance_sheet (annual, 2026-03-31) — Current Debt And Capital Lease Obligation: 32542000000.00
BABA balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 32542000000.00
BABA balance_sheet (annual, 2026-03-31) — Current Deferred Assets: 5479000000.00
BABA balance_sheet (quarterly, 2026-03-31) — Current Deferred Assets: 5479000000.00
BABA balance_sheet (annual, 2026-03-31) — Current Deferred Liabilities: 141307000000.00
BABA balance_sheet (quarterly, 2026-03-31) — Current Deferred Liabilities: 141307000000.00
BABA balance_sheet (annual, 2026-03-31) — Current Deferred Revenue: 77651000000.00
BABA balance_sheet (quarterly, 2026-03-31) — Current Deferred Revenue: 77651000000.00
BABA balance_sheet (annual, 2026-03-31) — Current Liabilities: 476398000000.00
BABA balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 476398000000.00
BABA cash_flow (annual, 2026-03-31) — Deferred Income Tax: -2528000000.00
BABA cash_flow (annual, 2026-03-31) — Deferred Tax: -2528000000.00
BABA cash_flow (annual, 2026-03-31) — Depreciation: 37067000000.00
BABA cash_flow (annual, 2026-03-31) — Depreciation Amortization Depletion: 47118000000.00
BABA income_statement (annual, 2026-03-31) — Depreciation Amortization Depletion Income Statement: 5079000000.00
BABA income_statement (quarterly, 2026-03-31) — Depreciation Amortization Depletion Income Statement: 2605000000.00
BABA cash_flow (annual, 2026-03-31) — Depreciation And Amortization: 47118000000.00
BABA income_statement (annual, 2026-03-31) — Depreciation And Amortization In Income Statement: 5079000000.00
BABA income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 2605000000.00
BABA income_statement (annual, 2026-03-31) — Diluted Average Shares: 2404375000.00
BABA income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 2414875000.00
BABA income_statement (annual, 2026-03-31) — Diluted EPS: 44.00
BABA income_statement (quarterly, 2026-03-31) — Diluted EPS: 10.40
BABA income_statement (annual, 2026-03-31) — Diluted NI Availto Com Stockholders: 105803000000.00
BABA income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 25472000000.00
BABA balance_sheet (annual, 2026-03-31) — Duefrom Related Parties Current: 21587000000.00
BABA balance_sheet (quarterly, 2026-03-31) — Duefrom Related Parties Current: 21587000000.00
BABA balance_sheet (annual, 2026-03-31) — Dueto Related Parties Current: 7563000000.00
BABA balance_sheet (quarterly, 2026-03-31) — Dueto Related Parties Current: 7563000000.00
BABA income_statement (annual, 2026-03-31) — EBIT: 139180000000.00
BABA income_statement (quarterly, 2026-03-31) — EBIT: 33598000000.00
BABA income_statement (annual, 2026-03-31) — EBITDA: 186298000000.00
BABA income_statement (quarterly, 2026-03-31) — EBITDA: 36203000000.00
BABA income_statement (annual, 2026-03-31) — Earnings From Equity Interest Net Of Tax: 2785000000.00
BABA income_statement (quarterly, 2026-03-31) — Earnings From Equity Interest Net Of Tax: -685000000.00
BABA cash_flow (annual, 2026-03-31) — Earnings Losses From Equity Investments: -2785000000.00
BABA cash_flow (annual, 2026-03-31) — Effect Of Exchange Rate Changes: -4004000000.00
BABA cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: -1063000000.00
BABA cash_flow (annual, 2026-03-31) — End Cash Position: 173568000000.00
BABA cash_flow (quarterly, 2026-03-31) — End Cash Position: 173568000000.00
BABA cash_flow (annual, 2026-03-31) — Financing Cash Flow: -20573000000.00
BABA cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -15002000000.00
BABA balance_sheet (annual, 2026-03-31) — Foreign Currency Translation Adjustments: -13404000000.00
BABA balance_sheet (quarterly, 2026-03-31) — Foreign Currency Translation Adjustments: -13404000000.00
BABA cash_flow (annual, 2026-03-31) — Free Cash Flow: -50724000000.00
BABA cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -117527000000.00
BABA cash_flow (annual, 2026-03-31) — Gain Loss On Investment Securities: -65990000000.00
BABA cash_flow (annual, 2026-03-31) — Gain Loss On Sale Of Business: -7858000000.00
BABA cash_flow (annual, 2026-03-31) — Gain Loss On Sale Of PPE: -1848000000.00
BABA balance_sheet (annual, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: 3558000000.00
BABA balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: 3558000000.00
BABA income_statement (annual, 2026-03-31) — General And Administrative Expense: 33082000000.00
BABA income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 9949000000.00
BABA balance_sheet (annual, 2026-03-31) — Goodwill: 247378000000.00
BABA balance_sheet (quarterly, 2026-03-31) — Goodwill: 247378000000.00
BABA balance_sheet (annual, 2026-03-31) — Goodwill And Other Intangible Assets: 275325000000.00
BABA balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 275325000000.00
BABA balance_sheet (annual, 2026-03-31) — Gross PPE: 482833000000.00
BABA balance_sheet (quarterly, 2026-03-31) — Gross PPE: 482833000000.00
BABA income_statement (annual, 2026-03-31) — Gross Profit: 407534000000.00
BABA income_statement (quarterly, 2026-03-31) — Gross Profit: 83988000000.00
BABA income_statement (annual, 2026-03-31) — Impairment Of Capital Assets: 9515000000.00
BABA income_statement (quarterly, 2026-03-31) — Impairment Of Capital Assets: 0.00
BABA balance_sheet (annual, 2026-03-31) — Income Tax Payable: 10630000000.00
BABA balance_sheet (quarterly, 2026-03-31) — Income Tax Payable: 10630000000.00
BABA income_statement (annual, 2026-03-31) — Interest Expense: 9793000000.00
BABA income_statement (quarterly, 2026-03-31) — Interest Expense: 2241000000.00
BABA income_statement (annual, 2026-03-31) — Interest Expense Non Operating: 9793000000.00
BABA income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 2241000000.00
BABA income_statement (annual, 2026-03-31) — Interest Income: 87512000000.00
BABA income_statement (quarterly, 2026-03-31) — Interest Income: 33823000000.00
BABA income_statement (annual, 2026-03-31) — Interest Income Non Operating: 87512000000.00
BABA income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 33823000000.00
BABA cash_flow (annual, 2026-03-31) — Interest Paid Supplemental Data: 9384000000.00
BABA balance_sheet (annual, 2026-03-31) — Inventory: 18909000000.00
BABA balance_sheet (quarterly, 2026-03-31) — Inventory: 18909000000.00
BABA balance_sheet (annual, 2026-03-31) — Invested Capital: 1320882000000.00
BABA balance_sheet (quarterly, 2026-03-31) — Invested Capital: 1320882000000.00
BABA cash_flow (annual, 2026-03-31) — Investing Cash Flow: -67336000000.00
BABA cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: 9704000000.00
BABA balance_sheet (annual, 2026-03-31) — Investmentin Financial Assets: 449942000000.00
BABA balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 449942000000.00
BABA balance_sheet (annual, 2026-03-31) — Investments And Advances: 656745000000.00
BABA balance_sheet (quarterly, 2026-03-31) — Investments And Advances: 656745000000.00
BABA cash_flow (annual, 2026-03-31) — Issuance Of Capital Stock: 1042000000.00
BABA cash_flow (annual, 2026-03-31) — Issuance Of Debt: 117490000000.00
BABA balance_sheet (annual, 2026-03-31) — Long Term Capital Lease Obligation: 17408000000.00
BABA balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 17408000000.00
BABA balance_sheet (annual, 2026-03-31) — Long Term Debt: 231772000000.00
BABA balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 231772000000.00
BABA balance_sheet (annual, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 249180000000.00
BABA balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 249180000000.00
BABA cash_flow (annual, 2026-03-31) — Long Term Debt Issuance: 117490000000.00
BABA cash_flow (annual, 2026-03-31) — Long Term Debt Payments: -78458000000.00
BABA balance_sheet (annual, 2026-03-31) — Long Term Equity Investment: 206803000000.00
BABA balance_sheet (quarterly, 2026-03-31) — Long Term Equity Investment: 206803000000.00
BABA balance_sheet (annual, 2026-03-31) — Machinery Furniture Equipment: 256489000000.00
BABA balance_sheet (quarterly, 2026-03-31) — Machinery Furniture Equipment: 256489000000.00
BABA balance_sheet (annual, 2026-03-31) — Minority Interest: 65384000000.00
BABA balance_sheet (quarterly, 2026-03-31) — Minority Interest: 65384000000.00
BABA income_statement (annual, 2026-03-31) — Minority Interests: 1465000000.00
BABA income_statement (quarterly, 2026-03-31) — Minority Interests: 2039000000.00
BABA cash_flow (annual, 2026-03-31) — Net Business Purchase And Sale: 12113000000.00
BABA cash_flow (annual, 2026-03-31) — Net Common Stock Issuance: -6596000000.00
BABA balance_sheet (annual, 2026-03-31) — Net Debt: 128466000000.00
BABA balance_sheet (quarterly, 2026-03-31) — Net Debt: 128466000000.00
BABA income_statement (annual, 2026-03-31) — Net Income: 103592000000.00
BABA income_statement (quarterly, 2026-03-31) — Net Income: 25541000000.00
BABA income_statement (annual, 2026-03-31) — Net Income Common Stockholders: 105904000000.00
BABA income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 25476000000.00
BABA income_statement (annual, 2026-03-31) — Net Income Continuous Operations: 102127000000.00
BABA income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 23502000000.00
BABA income_statement (annual, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 103592000000.00
BABA income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 25541000000.00
BABA income_statement (annual, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 103592000000.00
BABA income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 25541000000.00
BABA cash_flow (annual, 2026-03-31) — Net Income From Continuing Operations: 102127000000.00
BABA income_statement (annual, 2026-03-31) — Net Income Including Noncontrolling Interests: 102127000000.00
BABA income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 23502000000.00
BABA cash_flow (annual, 2026-03-31) — Net Intangibles Purchase And Sale: -874000000.00
BABA income_statement (annual, 2026-03-31) — Net Interest Income: 77719000000.00
BABA income_statement (quarterly, 2026-03-31) — Net Interest Income: 31582000000.00
BABA cash_flow (annual, 2026-03-31) — Net Investment Purchase And Sale: 46709000000.00
BABA cash_flow (annual, 2026-03-31) — Net Issuance Payments Of Debt: 39032000000.00
BABA cash_flow (annual, 2026-03-31) — Net Long Term Debt Issuance: 39032000000.00
BABA income_statement (annual, 2026-03-31) — Net Non Operating Interest Income Expense: 77719000000.00
BABA income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: 31582000000.00
BABA cash_flow (annual, 2026-03-31) — Net Other Financing Charges: -19277000000.00
BABA cash_flow (annual, 2026-03-31) — Net Other Investing Changes: 238000000.00
BABA balance_sheet (annual, 2026-03-31) — Net PPE: 332010000000.00
BABA balance_sheet (quarterly, 2026-03-31) — Net PPE: 332010000000.00
BABA cash_flow (annual, 2026-03-31) — Net PPE Purchase And Sale: -125522000000.00
BABA balance_sheet (annual, 2026-03-31) — Net Tangible Assets: 785561000000.00
BABA balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 785561000000.00
BABA balance_sheet (annual, 2026-03-31) — Non Current Deferred Assets: 13957000000.00
BABA balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Assets: 13957000000.00
BABA balance_sheet (annual, 2026-03-31) — Non Current Deferred Liabilities: 51883000000.00
BABA balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 51883000000.00
BABA balance_sheet (annual, 2026-03-31) — Non Current Deferred Revenue: 4885000000.00
BABA balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Revenue: 4885000000.00
BABA balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Assets: 13957000000.00
BABA balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 13957000000.00
BABA balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Liabilities: 46060000000.00
BABA balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 46060000000.00
BABA income_statement (annual, 2026-03-31) — Normalized EBITDA: 195813000000.00
BABA income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 36203000000.00
BABA income_statement (annual, 2026-03-31) — Normalized Income: 110897518560.60
BABA income_statement (quarterly, 2026-03-31) — Normalized Income: 25541000000.00
BABA cash_flow (annual, 2026-03-31) — Operating Cash Flow: 76213000000.00
BABA cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 9410000000.00
BABA cash_flow (annual, 2026-03-31) — Operating Gains Losses: -78481000000.00
BABA income_statement (annual, 2026-03-31) — Operating Income: 59665000000.00
BABA income_statement (quarterly, 2026-03-31) — Operating Income: -848000000.00
BABA income_statement (annual, 2026-03-31) — Operating Revenue: 987243000000.00
BABA income_statement (quarterly, 2026-03-31) — Operating Revenue: 206953000000.00
BABA balance_sheet (annual, 2026-03-31) — Ordinary Shares Number: 18580374278.00
BABA balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 18580374278.00
BABA balance_sheet (annual, 2026-03-31) — Other Current Assets: 20114000000.00
BABA balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 20114000000.00
BABA balance_sheet (annual, 2026-03-31) — Other Current Borrowings: 28224000000.00
BABA balance_sheet (quarterly, 2026-03-31) — Other Current Borrowings: 28224000000.00
BABA balance_sheet (annual, 2026-03-31) — Other Current Liabilities: 24940000000.00
BABA balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 24940000000.00
BABA balance_sheet (annual, 2026-03-31) — Other Equity Adjustments: 16628000000.00
BABA balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: 16628000000.00
BABA income_statement (annual, 2026-03-31) — Other Gand A: 33082000000.00
BABA income_statement (quarterly, 2026-03-31) — Other Gand A: 9949000000.00
BABA income_statement (annual, 2026-03-31) — Other Income Expense: -7997000000.00
BABA income_statement (quarterly, 2026-03-31) — Other Income Expense: 623000000.00
BABA balance_sheet (annual, 2026-03-31) — Other Intangible Assets: 27947000000.00
BABA balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 27947000000.00
BABA cash_flow (annual, 2026-03-31) — Other Non Cash Items: -992000000.00
BABA balance_sheet (annual, 2026-03-31) — Other Non Current Assets: 20764000000.00
BABA balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 20764000000.00
BABA balance_sheet (annual, 2026-03-31) — Other Non Current Liabilities: 5839000000.00
BABA balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 5839000000.00
BABA income_statement (annual, 2026-03-31) — Other Non Operating Income Expenses: 1518000000.00
BABA income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 623000000.00
BABA income_statement (annual, 2026-03-31) — Other Operating Expenses: -1848000000.00
BABA income_statement (quarterly, 2026-03-31) — Other Operating Expenses: -90000000.00
BABA balance_sheet (annual, 2026-03-31) — Other Payable: 220024000000.00
BABA balance_sheet (quarterly, 2026-03-31) — Other Payable: 220024000000.00
BABA balance_sheet (annual, 2026-03-31) — Other Properties: 45524000000.00
BABA balance_sheet (quarterly, 2026-03-31) — Other Properties: 45524000000.00
BABA balance_sheet (annual, 2026-03-31) — Other Receivables: 90671000000.00
BABA balance_sheet (quarterly, 2026-03-31) — Other Receivables: 90671000000.00
BABA balance_sheet (annual, 2026-03-31) — Other Short Term Investments: 185364000000.00
BABA balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 185364000000.00
BABA income_statement (annual, 2026-03-31) — Otherunder Preferred Stock Dividend: -2312000000.00
BABA income_statement (quarterly, 2026-03-31) — Otherunder Preferred Stock Dividend: 65000000.00
BABA balance_sheet (annual, 2026-03-31) — Payables: 245152000000.00
BABA balance_sheet (quarterly, 2026-03-31) — Payables: 245152000000.00
BABA balance_sheet (annual, 2026-03-31) — Payables And Accrued Expenses: 277609000000.00
BABA balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 277609000000.00
BABA balance_sheet (annual, 2026-03-31) — Prepaid Assets: 22556000000.00
BABA balance_sheet (quarterly, 2026-03-31) — Prepaid Assets: 22556000000.00
BABA income_statement (annual, 2026-03-31) — Pretax Income: 129387000000.00
BABA income_statement (quarterly, 2026-03-31) — Pretax Income: 31357000000.00
BABA balance_sheet (annual, 2026-03-31) — Properties: 0.00
BABA balance_sheet (quarterly, 2026-03-31) — Properties: 0.00
BABA cash_flow (annual, 2026-03-31) — Provisionand Write Offof Assets: 1368000000.00
BABA cash_flow (annual, 2026-03-31) — Purchase Of Business: -4935000000.00
BABA cash_flow (annual, 2026-03-31) — Purchase Of Intangibles: -874000000.00
BABA cash_flow (annual, 2026-03-31) — Purchase Of Investment: -76440000000.00
BABA cash_flow (annual, 2026-03-31) — Purchase Of PPE: -126063000000.00
BABA balance_sheet (annual, 2026-03-31) — Receivables: 184779000000.00
BABA balance_sheet (quarterly, 2026-03-31) — Receivables: 184779000000.00
BABA income_statement (annual, 2026-03-31) — Reconciled Cost Of Revenue: 574097000000.00
BABA income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 159392000000.00
BABA income_statement (annual, 2026-03-31) — Reconciled Depreciation: 47118000000.00
BABA income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 2605000000.00
BABA cash_flow (annual, 2026-03-31) — Repayment Of Debt: -78458000000.00
BABA cash_flow (annual, 2026-03-31) — Repurchase Of Capital Stock: -7638000000.00
BABA income_statement (annual, 2026-03-31) — Research And Development: 66533000000.00
BABA income_statement (quarterly, 2026-03-31) — Research And Development: 18957000000.00
BABA balance_sheet (annual, 2026-03-31) — Restricted Cash: 42038000000.00
BABA balance_sheet (quarterly, 2026-03-31) — Restricted Cash: 42038000000.00
BABA balance_sheet (annual, 2026-03-31) — Retained Earnings: 708382000000.00
BABA balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 708382000000.00
BABA cash_flow (annual, 2026-03-31) — Sale Of Business: 17048000000.00
BABA cash_flow (annual, 2026-03-31) — Sale Of Investment: 123149000000.00
BABA cash_flow (annual, 2026-03-31) — Sale Of PPE: 541000000.00
BABA income_statement (annual, 2026-03-31) — Selling And Marketing Expense: 245023000000.00
BABA income_statement (quarterly, 2026-03-31) — Selling And Marketing Expense: 53415000000.00
BABA income_statement (annual, 2026-03-31) — Selling General And Administration: 278105000000.00
BABA income_statement (quarterly, 2026-03-31) — Selling General And Administration: 63364000000.00
BABA balance_sheet (annual, 2026-03-31) — Share Issued: 18580374278.00
BABA balance_sheet (quarterly, 2026-03-31) — Share Issued: 18580374278.00
BABA income_statement (annual, 2026-03-31) — Special Income Charges: -9515000000.00
BABA income_statement (quarterly, 2026-03-31) — Special Income Charges: 0.00
BABA cash_flow (annual, 2026-03-31) — Stock Based Compensation: 11180000000.00
BABA balance_sheet (annual, 2026-03-31) — Stockholders Equity: 1060886000000.00
BABA balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 1060886000000.00
BABA balance_sheet (annual, 2026-03-31) — Tangible Book Value: 785561000000.00
BABA balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 785561000000.00
BABA income_statement (annual, 2026-03-31) — Tax Effect Of Unusual Items: -2209481439.40
BABA income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
BABA income_statement (annual, 2026-03-31) — Tax Provision: 30045000000.00
BABA income_statement (quarterly, 2026-03-31) — Tax Provision: 7170000000.00
BABA income_statement (annual, 2026-03-31) — Tax Rate For Calcs: 0.23
BABA income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.23
BABA balance_sheet (annual, 2026-03-31) — Taxes Receivable: 32303000000.00
BABA balance_sheet (quarterly, 2026-03-31) — Taxes Receivable: 32303000000.00
BABA balance_sheet (annual, 2026-03-31) — Total Assets: 1909570000000.00
BABA balance_sheet (quarterly, 2026-03-31) — Total Assets: 1909570000000.00
BABA balance_sheet (annual, 2026-03-31) — Total Capitalization: 1292658000000.00
BABA balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 1292658000000.00
BABA balance_sheet (annual, 2026-03-31) — Total Debt: 281722000000.00
BABA balance_sheet (quarterly, 2026-03-31) — Total Debt: 281722000000.00
BABA balance_sheet (annual, 2026-03-31) — Total Equity Gross Minority Interest: 1126270000000.00
BABA balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 1126270000000.00
BABA income_statement (annual, 2026-03-31) — Total Expenses: 964005000000.00
BABA income_statement (quarterly, 2026-03-31) — Total Expenses: 244228000000.00
BABA balance_sheet (annual, 2026-03-31) — Total Liabilities Net Minority Interest: 783300000000.00
BABA balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 783300000000.00
BABA balance_sheet (annual, 2026-03-31) — Total Non Current Assets: 1298801000000.00
BABA balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 1298801000000.00
BABA balance_sheet (annual, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 306902000000.00
BABA balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 306902000000.00
BABA income_statement (annual, 2026-03-31) — Total Operating Income As Reported: 50150000000.00
BABA income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: -848000000.00
BABA balance_sheet (annual, 2026-03-31) — Total Tax Payable: 17565000000.00
BABA balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 17565000000.00
BABA income_statement (annual, 2026-03-31) — Total Unusual Items: -9515000000.00
BABA income_statement (quarterly, 2026-03-31) — Total Unusual Items: 0.00
BABA income_statement (annual, 2026-03-31) — Total Unusual Items Excluding Goodwill: -9515000000.00
BABA income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: 0.00
BABA balance_sheet (annual, 2026-03-31) — Treasury Stock: 36141000000.00
BABA balance_sheet (quarterly, 2026-03-31) — Treasury Stock: 36141000000.00
BABA balance_sheet (annual, 2026-03-31) — Unrealized Gain Loss: 334000000.00
BABA balance_sheet (quarterly, 2026-03-31) — Unrealized Gain Loss: 334000000.00
BABA balance_sheet (annual, 2026-03-31) — Working Capital: 134371000000.00
BABA balance_sheet (quarterly, 2026-03-31) — Working Capital: 134371000000.00
BABY.TO cash_flow (annual, 2021-12-31) — Capital Expenditure: -287000.00
BABY.TO balance_sheet (annual, 2021-12-31) — Derivative Product Liabilities: 2243000.00
BABY.TO balance_sheet (annual, 2021-12-31) — Long Term Capital Lease Obligation: 590000.00
BABY.TO balance_sheet (annual, 2021-12-31) — Long Term Debt And Capital Lease Obligation: 590000.00
BABY.TO cash_flow (annual, 2021-12-31) — Net Other Financing Charges: -147000.00
BABY.TO balance_sheet (annual, 2021-12-31) — Other Short Term Investments: 1229000.00
BABY.TO cash_flow (annual, 2021-12-31) — Sale Of Investment: 1940000.00
BABY.TO income_statement (annual, 2022-12-31) — +Operating Expense: 21907000.00
BABY.TO income_statement (annual, 2022-12-31) — +Total Revenue: 8527000.00
BABY.TO balance_sheet (annual, 2022-12-31) — Accounts Payable: 2199000.00
BABY.TO balance_sheet (annual, 2022-12-31) — Accounts Receivable: 1495000.00
BABY.TO balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -212000.00
BABY.TO income_statement (annual, 2022-12-31) — Basic Average Shares: 108684822.00
BABY.TO income_statement (annual, 2022-12-31) — Basic EPS: -0.16
BABY.TO cash_flow (annual, 2022-12-31) — Beginning Cash Position: 23047000.00
BABY.TO cash_flow (annual, 2022-12-31) — Capital Expenditure: -160000.00
BABY.TO balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 558000.00
BABY.TO balance_sheet (annual, 2022-12-31) — Capital Stock: 59716000.00
BABY.TO balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 14564000.00
BABY.TO balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 15381000.00
BABY.TO cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: 11689000.00
BABY.TO cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: 170000.00
BABY.TO cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: -20911000.00
BABY.TO cash_flow (annual, 2022-12-31) — Change In Account Payable: 244000.00
BABY.TO cash_flow (annual, 2022-12-31) — Change In Inventory: -1020000.00
BABY.TO cash_flow (annual, 2022-12-31) — Change In Payable: 141000.00
BABY.TO cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: 141000.00
BABY.TO cash_flow (annual, 2022-12-31) — Change In Receivables: -1173000.00
BABY.TO cash_flow (annual, 2022-12-31) — Change In Working Capital: -2052000.00
BABY.TO cash_flow (annual, 2022-12-31) — Changes In Account Receivables: -774000.00
BABY.TO cash_flow (annual, 2022-12-31) — Changes In Cash: -9052000.00
BABY.TO balance_sheet (annual, 2022-12-31) — Common Stock: 59716000.00
BABY.TO balance_sheet (annual, 2022-12-31) — Common Stock Equity: 15595000.00
BABY.TO cash_flow (annual, 2022-12-31) — Common Stock Issuance: 6743000.00
BABY.TO income_statement (annual, 2022-12-31) — Cost Of Revenue: 7216000.00
BABY.TO balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 923000.00
BABY.TO balance_sheet (annual, 2022-12-31) — Current Assets: 24789000.00
BABY.TO balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 238000.00
BABY.TO balance_sheet (annual, 2022-12-31) — Current Debt: 982000.00
BABY.TO balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 1220000.00
BABY.TO balance_sheet (annual, 2022-12-31) — Current Liabilities: 8423000.00
BABY.TO cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 496000.00
BABY.TO income_statement (annual, 2022-12-31) — Depreciation Amortization Depletion Income Statement: 496000.00
BABY.TO cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 496000.00
BABY.TO income_statement (annual, 2022-12-31) — Depreciation And Amortization In Income Statement: 496000.00
BABY.TO balance_sheet (annual, 2022-12-31) — Derivative Product Liabilities: 4072000.00
BABY.TO income_statement (annual, 2022-12-31) — Diluted Average Shares: 108684822.00
BABY.TO income_statement (annual, 2022-12-31) — Diluted EPS: -1.62
BABY.TO income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: -17614000.00
BABY.TO balance_sheet (annual, 2022-12-31) — Dueto Related Parties Current: 9000.00
BABY.TO income_statement (annual, 2022-12-31) — EBIT: -17601000.00
BABY.TO income_statement (annual, 2022-12-31) — EBITDA: -17105000.00
BABY.TO cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: 569000.00
BABY.TO cash_flow (annual, 2022-12-31) — End Cash Position: 14564000.00
BABY.TO cash_flow (annual, 2022-12-31) — Financing Cash Flow: 11689000.00
BABY.TO balance_sheet (annual, 2022-12-31) — Finished Goods: 805000.00
BABY.TO cash_flow (annual, 2022-12-31) — Free Cash Flow: -21071000.00
BABY.TO cash_flow (annual, 2022-12-31) — Gain Loss On Investment Securities: -2870000.00
BABY.TO income_statement (annual, 2022-12-31) — Gain On Sale Of Security: 2921000.00
BABY.TO balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: -44000.00
BABY.TO income_statement (annual, 2022-12-31) — General And Administrative Expense: 9708000.00
BABY.TO balance_sheet (annual, 2022-12-31) — Goodwill: 48000.00
BABY.TO balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 263000.00
BABY.TO balance_sheet (annual, 2022-12-31) — Gross PPE: 1111000.00
BABY.TO income_statement (annual, 2022-12-31) — Gross Profit: 1311000.00
BABY.TO income_statement (annual, 2022-12-31) — Interest Expense: 13000.00
BABY.TO income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 13000.00
BABY.TO income_statement (annual, 2022-12-31) — Interest Income: 74000.00
BABY.TO income_statement (annual, 2022-12-31) — Interest Income Non Operating: 74000.00
BABY.TO balance_sheet (annual, 2022-12-31) — Inventory: 5910000.00
BABY.TO balance_sheet (annual, 2022-12-31) — Invested Capital: 18402000.00
BABY.TO cash_flow (annual, 2022-12-31) — Investing Cash Flow: 170000.00
BABY.TO cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 6743000.00
BABY.TO cash_flow (annual, 2022-12-31) — Issuance Of Debt: 5281000.00
BABY.TO balance_sheet (annual, 2022-12-31) — Leases: 70000.00
BABY.TO balance_sheet (annual, 2022-12-31) — Line Of Credit: 0.00
BABY.TO balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 320000.00
BABY.TO balance_sheet (annual, 2022-12-31) — Long Term Debt: 1825000.00
BABY.TO balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 2145000.00
BABY.TO cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 5281000.00
BABY.TO cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -335000.00
BABY.TO balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 276000.00
BABY.TO cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: 6743000.00
BABY.TO income_statement (annual, 2022-12-31) — Net Income: -17614000.00
BABY.TO income_statement (annual, 2022-12-31) — Net Income Common Stockholders: -17614000.00
BABY.TO income_statement (annual, 2022-12-31) — Net Income Continuous Operations: -17614000.00
BABY.TO income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: -17614000.00
BABY.TO income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: -17614000.00
BABY.TO cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: -17614000.00
BABY.TO income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: -17614000.00
BABY.TO income_statement (annual, 2022-12-31) — Net Interest Income: 61000.00
BABY.TO cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: 341000.00
BABY.TO cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: 4946000.00
BABY.TO cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: 4946000.00
BABY.TO income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: 61000.00
BABY.TO cash_flow (annual, 2022-12-31) — Net Other Investing Changes: -11000.00
BABY.TO balance_sheet (annual, 2022-12-31) — Net PPE: 1111000.00
BABY.TO cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -160000.00
BABY.TO balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 15332000.00
BABY.TO income_statement (annual, 2022-12-31) — Normalized EBITDA: -20026000.00
BABY.TO income_statement (annual, 2022-12-31) — Normalized Income: -20535000.00
BABY.TO cash_flow (annual, 2022-12-31) — Operating Cash Flow: -20911000.00
BABY.TO cash_flow (annual, 2022-12-31) — Operating Gains Losses: -2870000.00
BABY.TO income_statement (annual, 2022-12-31) — Operating Income: -20596000.00
BABY.TO income_statement (annual, 2022-12-31) — Operating Revenue: 8527000.00
BABY.TO balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 112600220.00
BABY.TO balance_sheet (annual, 2022-12-31) — Other Current Borrowings: 982000.00
BABY.TO balance_sheet (annual, 2022-12-31) — Other Current Liabilities: 4072000.00
BABY.TO balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: -44000.00
BABY.TO balance_sheet (annual, 2022-12-31) — Other Equity Interest: 4791000.00
BABY.TO income_statement (annual, 2022-12-31) — Other Gand A: 2585000.00
BABY.TO income_statement (annual, 2022-12-31) — Other Income Expense: 2921000.00
BABY.TO balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 215000.00
BABY.TO cash_flow (annual, 2022-12-31) — Other Non Cash Items: 35000.00
BABY.TO income_statement (annual, 2022-12-31) — Other Operating Expenses: 3184000.00
BABY.TO balance_sheet (annual, 2022-12-31) — Other Payable: 923000.00
BABY.TO balance_sheet (annual, 2022-12-31) — Other Properties: 1111000.00
BABY.TO balance_sheet (annual, 2022-12-31) — Other Receivables: 823000.00
BABY.TO balance_sheet (annual, 2022-12-31) — Other Short Term Investments: 817000.00
BABY.TO balance_sheet (annual, 2022-12-31) — Payables: 3131000.00
BABY.TO balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 3131000.00
BABY.TO balance_sheet (annual, 2022-12-31) — Prepaid Assets: 776000.00
BABY.TO income_statement (annual, 2022-12-31) — Pretax Income: -17614000.00
BABY.TO cash_flow (annual, 2022-12-31) — Proceeds From Stock Option Exercised: 0.00
BABY.TO balance_sheet (annual, 2022-12-31) — Properties: 0.00
BABY.TO cash_flow (annual, 2022-12-31) — Purchase Of PPE: -160000.00
BABY.TO balance_sheet (annual, 2022-12-31) — Raw Materials: 3152000.00
BABY.TO balance_sheet (annual, 2022-12-31) — Receivables: 2318000.00
BABY.TO income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 7216000.00
BABY.TO income_statement (annual, 2022-12-31) — Reconciled Depreciation: 496000.00
BABY.TO cash_flow (annual, 2022-12-31) — Repayment Of Debt: -335000.00
BABY.TO income_statement (annual, 2022-12-31) — Research And Development: 2564000.00
BABY.TO balance_sheet (annual, 2022-12-31) — Restricted Cash: 1180000.00
BABY.TO balance_sheet (annual, 2022-12-31) — Retained Earnings: -48868000.00
BABY.TO income_statement (annual, 2022-12-31) — Salaries And Wages: 7123000.00
BABY.TO income_statement (annual, 2022-12-31) — Selling And Marketing Expense: 5955000.00
BABY.TO income_statement (annual, 2022-12-31) — Selling General And Administration: 15663000.00
BABY.TO balance_sheet (annual, 2022-12-31) — Share Issued: 112600220.00
BABY.TO cash_flow (annual, 2022-12-31) — Stock Based Compensation: 1094000.00
BABY.TO balance_sheet (annual, 2022-12-31) — Stockholders Equity: 15595000.00
BABY.TO balance_sheet (annual, 2022-12-31) — Tangible Book Value: 15332000.00
BABY.TO income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 0.00
BABY.TO income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.00
BABY.TO balance_sheet (annual, 2022-12-31) — Total Assets: 26163000.00
BABY.TO balance_sheet (annual, 2022-12-31) — Total Capitalization: 17420000.00
BABY.TO balance_sheet (annual, 2022-12-31) — Total Debt: 3365000.00
BABY.TO balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 15595000.00
BABY.TO income_statement (annual, 2022-12-31) — Total Expenses: 29123000.00
BABY.TO balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 10568000.00
BABY.TO balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 1374000.00
BABY.TO balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 2145000.00
BABY.TO income_statement (annual, 2022-12-31) — Total Unusual Items: 2921000.00
BABY.TO income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: 2921000.00
BABY.TO balance_sheet (annual, 2022-12-31) — Work In Process: 1953000.00
BABY.TO balance_sheet (annual, 2022-12-31) — Working Capital: 16366000.00
BABY.TO income_statement (annual, 2023-12-31) — +Operating Expense: 16926000.00
BABY.TO income_statement (annual, 2023-12-31) — +Total Revenue: 9361000.00
BABY.TO balance_sheet (annual, 2023-12-31) — Accounts Payable: 1719000.00
BABY.TO balance_sheet (annual, 2023-12-31) — Accounts Receivable: 1340000.00
BABY.TO balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -293000.00
BABY.TO income_statement (annual, 2023-12-31) — Basic Average Shares: 116778704.00
BABY.TO income_statement (annual, 2023-12-31) — Basic EPS: -0.13
BABY.TO cash_flow (annual, 2023-12-31) — Beginning Cash Position: 14564000.00
BABY.TO balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 303000.00
BABY.TO balance_sheet (annual, 2023-12-31) — Capital Stock: 65948000.00
BABY.TO balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 2931000.00
BABY.TO balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 4925000.00
BABY.TO cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: 7443000.00
BABY.TO cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -1126000.00
BABY.TO cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: -18311000.00
BABY.TO cash_flow (annual, 2023-12-31) — Change In Account Payable: -411000.00
BABY.TO cash_flow (annual, 2023-12-31) — Change In Inventory: -1531000.00
BABY.TO cash_flow (annual, 2023-12-31) — Change In Payable: -54000.00
BABY.TO cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: -54000.00
BABY.TO cash_flow (annual, 2023-12-31) — Change In Receivables: 265000.00
BABY.TO cash_flow (annual, 2023-12-31) — Change In Working Capital: -1320000.00
BABY.TO cash_flow (annual, 2023-12-31) — Changes In Account Receivables: 58000.00
BABY.TO cash_flow (annual, 2023-12-31) — Changes In Cash: -11994000.00
BABY.TO balance_sheet (annual, 2023-12-31) — Common Stock: 65948000.00
BABY.TO balance_sheet (annual, 2023-12-31) — Common Stock Equity: 6721000.00
BABY.TO cash_flow (annual, 2023-12-31) — Common Stock Issuance: 4394000.00
BABY.TO income_statement (annual, 2023-12-31) — Cost Of Revenue: 9446000.00
BABY.TO balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 1244000.00
BABY.TO balance_sheet (annual, 2023-12-31) — Current Assets: 15127000.00
BABY.TO balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 194000.00
BABY.TO balance_sheet (annual, 2023-12-31) — Current Debt: 2435000.00
BABY.TO balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 2629000.00
BABY.TO balance_sheet (annual, 2023-12-31) — Current Liabilities: 8886000.00
BABY.TO cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 379000.00
BABY.TO income_statement (annual, 2023-12-31) — Depreciation Amortization Depletion Income Statement: 379000.00
BABY.TO cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 379000.00
BABY.TO income_statement (annual, 2023-12-31) — Depreciation And Amortization In Income Statement: 379000.00
BABY.TO balance_sheet (annual, 2023-12-31) — Derivative Product Liabilities: 3283000.00
BABY.TO income_statement (annual, 2023-12-31) — Diluted Average Shares: 129778704.00
BABY.TO income_statement (annual, 2023-12-31) — Diluted EPS: -0.13
BABY.TO income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: -15609000.00
BABY.TO balance_sheet (annual, 2023-12-31) — Dueto Related Parties Current: 11000.00
BABY.TO income_statement (annual, 2023-12-31) — EBIT: -15546000.00
BABY.TO income_statement (annual, 2023-12-31) — EBITDA: -15167000.00
BABY.TO cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: 361000.00
BABY.TO cash_flow (annual, 2023-12-31) — End Cash Position: 2931000.00
BABY.TO cash_flow (annual, 2023-12-31) — Financing Cash Flow: 7443000.00
BABY.TO balance_sheet (annual, 2023-12-31) — Finished Goods: 3422000.00
BABY.TO cash_flow (annual, 2023-12-31) — Free Cash Flow: -18311000.00
BABY.TO cash_flow (annual, 2023-12-31) — Gain Loss On Investment Securities: -4667000.00
BABY.TO income_statement (annual, 2023-12-31) — Gain On Sale Of Security: 3934000.00
BABY.TO balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: -3000.00
BABY.TO income_statement (annual, 2023-12-31) — General And Administrative Expense: 7274000.00
BABY.TO balance_sheet (annual, 2023-12-31) — Goodwill: 46000.00
BABY.TO balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 193000.00
BABY.TO balance_sheet (annual, 2023-12-31) — Gross PPE: 1042000.00
BABY.TO income_statement (annual, 2023-12-31) — Gross Profit: -85000.00
BABY.TO income_statement (annual, 2023-12-31) — Interest Expense: 63000.00
BABY.TO income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 63000.00
BABY.TO income_statement (annual, 2023-12-31) — Interest Income: 62000.00
BABY.TO income_statement (annual, 2023-12-31) — Interest Income Non Operating: 62000.00
BABY.TO balance_sheet (annual, 2023-12-31) — Inventory: 7258000.00
BABY.TO balance_sheet (annual, 2023-12-31) — Invested Capital: 9509000.00
BABY.TO cash_flow (annual, 2023-12-31) — Investing Cash Flow: -1126000.00
BABY.TO cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 4394000.00
BABY.TO cash_flow (annual, 2023-12-31) — Issuance Of Debt: 3231000.00
BABY.TO balance_sheet (annual, 2023-12-31) — Leases: 67000.00
BABY.TO balance_sheet (annual, 2023-12-31) — Line Of Credit: 0.00
BABY.TO balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 109000.00
BABY.TO balance_sheet (annual, 2023-12-31) — Long Term Debt: 353000.00
BABY.TO balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 462000.00
BABY.TO cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 3231000.00
BABY.TO cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -227000.00
BABY.TO balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 264000.00
BABY.TO cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: 4394000.00
BABY.TO income_statement (annual, 2023-12-31) — Net Income: -15609000.00
BABY.TO income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -15609000.00
BABY.TO income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -15609000.00
BABY.TO income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -15609000.00
BABY.TO income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -15609000.00
BABY.TO cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: -15609000.00
BABY.TO income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -15609000.00
BABY.TO income_statement (annual, 2023-12-31) — Net Interest Income: -1000.00
BABY.TO cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: -1256000.00
BABY.TO cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: 3004000.00
BABY.TO cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: 3004000.00
BABY.TO income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: -1000.00
BABY.TO cash_flow (annual, 2023-12-31) — Net Other Investing Changes: 130000.00
BABY.TO balance_sheet (annual, 2023-12-31) — Net PPE: 749000.00
BABY.TO cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: 0.00
BABY.TO balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 6528000.00
BABY.TO income_statement (annual, 2023-12-31) — Normalized EBITDA: -19101000.00
BABY.TO income_statement (annual, 2023-12-31) — Normalized Income: -19543000.00
BABY.TO cash_flow (annual, 2023-12-31) — Operating Cash Flow: -18311000.00
BABY.TO cash_flow (annual, 2023-12-31) — Operating Gains Losses: -4667000.00
BABY.TO income_statement (annual, 2023-12-31) — Operating Income: -17011000.00
BABY.TO income_statement (annual, 2023-12-31) — Operating Revenue: 9361000.00
BABY.TO balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 136094159.00
BABY.TO balance_sheet (annual, 2023-12-31) — Other Current Borrowings: 2435000.00
BABY.TO balance_sheet (annual, 2023-12-31) — Other Current Liabilities: 3283000.00
BABY.TO balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: -3000.00
BABY.TO balance_sheet (annual, 2023-12-31) — Other Equity Interest: 5253000.00
BABY.TO income_statement (annual, 2023-12-31) — Other Gand A: 2097000.00
BABY.TO income_statement (annual, 2023-12-31) — Other Income Expense: 1403000.00
BABY.TO balance_sheet (annual, 2023-12-31) — Other Intangible Assets: 147000.00
BABY.TO cash_flow (annual, 2023-12-31) — Other Non Cash Items: 2553000.00
BABY.TO income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: -2531000.00
BABY.TO income_statement (annual, 2023-12-31) — Other Operating Expenses: 2336000.00
BABY.TO balance_sheet (annual, 2023-12-31) — Other Properties: 711000.00
BABY.TO balance_sheet (annual, 2023-12-31) — Other Receivables: 166000.00
BABY.TO balance_sheet (annual, 2023-12-31) — Other Short Term Investments: 1994000.00
BABY.TO balance_sheet (annual, 2023-12-31) — Payables: 1730000.00
BABY.TO balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 2974000.00
BABY.TO balance_sheet (annual, 2023-12-31) — Prepaid Assets: 435000.00
BABY.TO income_statement (annual, 2023-12-31) — Pretax Income: -15609000.00
BABY.TO cash_flow (annual, 2023-12-31) — Proceeds From Stock Option Exercised: 45000.00
BABY.TO balance_sheet (annual, 2023-12-31) — Properties: 0.00
BABY.TO cash_flow (annual, 2023-12-31) — Purchase Of PPE: 0.00
BABY.TO balance_sheet (annual, 2023-12-31) — Raw Materials: 3006000.00
BABY.TO balance_sheet (annual, 2023-12-31) — Receivables: 1506000.00
BABY.TO income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 9446000.00
BABY.TO income_statement (annual, 2023-12-31) — Reconciled Depreciation: 379000.00
BABY.TO cash_flow (annual, 2023-12-31) — Repayment Of Debt: -227000.00
BABY.TO income_statement (annual, 2023-12-31) — Research And Development: 2559000.00
BABY.TO balance_sheet (annual, 2023-12-31) — Restricted Cash: 1003000.00